Cell & Gene Therapies: A Regulatory Update
Related Insights
Blog
CAR-T product development: an assessment of FDA’s final guidance for industry
Feb 27, 2024
Podcast
Rare endpoints: Delivering on unmet patient needs
May 7, 2024
Playbook
Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success
Mar 28, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Blog
CAR-T boxed warnings: regulatory precedents and opportunities
Feb 9, 2024
Podcast
CAR-T boxed warnings: What comes next?
Mar 6, 2024
Article
Three ways to improve your chances that insurers will pay for a new CGT
Feb 18, 2021
Blog
Regulatory considerations in designing clinical trials for Alzheimer’s disease
Jan 24, 2024
Webinar
How to navigate China’s regulatory environment
Feb 15, 2023
Whitepaper
The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations
Mar 9, 2023
Related Insights
Blog
CAR-T product development: an assessment of FDA’s final guidance for industry
Feb 27, 2024
Podcast
Rare endpoints: Delivering on unmet patient needs
May 7, 2024
Playbook
Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success
Mar 28, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Blog
CAR-T boxed warnings: regulatory precedents and opportunities
Feb 9, 2024
Podcast
CAR-T boxed warnings: What comes next?
Mar 6, 2024
Article
Three ways to improve your chances that insurers will pay for a new CGT
Feb 18, 2021
Blog
Regulatory considerations in designing clinical trials for Alzheimer’s disease
Jan 24, 2024
Webinar
How to navigate China’s regulatory environment
Feb 15, 2023
Whitepaper
The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations
Mar 9, 2023